Puma Biotech News, Puma Biotech Quote, PBYI Quote

Puma Biotech (NQ:PBYI) Delayed: 11.09 +0.07 (0.64%)

Prev. Close

$11.02

Today 6M 1Y 5Y

Open

$11.11

52 Wk High

$82.81

52 Wk Low

$19.74

Day High

$11.14

Day Low

$11.07

P/E

N/A

EPS

$-2.16

Volume

10,533

Friends, Peers and Foes (?): AZN NBI (more...)

ALERTS | RSS

Oct 22, 2026 04:11 PM Puma Biotechnology to Host Conference Call to Discuss Third Quarter 2026 Financial Results
Oct 6, 2026 09:37 PM Form SCHEDULE 13D/A PUMA BIOTECHNOLOGY, INC. Filed by: AUERBACH ALAN H
Oct 5, 2026 05:00 PM Puma Biotechnology Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
Sep 17, 2026 04:07 PM Puma Biotechnology starts phase II lung cancer trial with alisertib
Sep 17, 2026 04:07 PM Puma Biotechnology Initiates ALISCA®-Lung2, a Phase II Trial of Alisertib in Combination with Paclitaxel for the Treatment of Patients with Advanced Small Cell Lung Cancer
Sep 16, 2026 09:14 PM Form 4 PUMA BIOTECHNOLOGY, INC. For: Sep 14 Filed by: WILSON TROY EDWARD
Sep 16, 2026 09:06 PM Form 4 PUMA BIOTECHNOLOGY, INC. For: Sep 14 Filed by: Cesano Alessandra
Sep 14, 2026 12:05 PM Form 144 PUMA BIOTECHNOLOGY, INC. Filed by: Cesano Alessandra
Sep 14, 2026 12:02 PM Form 144 PUMA BIOTECHNOLOGY, INC. Filed by: WILSON TROY EDWARD
Aug 7, 2026 08:52 AM Puma Biotechnology (PBYI) PT Raised to $6 at TD Cowen

Entities mentioned with PBYI

View All Entities